Page last updated: 2024-09-03

imatinib mesylate and Gynecomastia

imatinib mesylate has been researched along with Gynecomastia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basciani, S; Brama, M; Giona, F; Gnessi, L; Mariani, S1
Li, C; Meng, L; Wang, G; Zhao, D1
Barutca, S; Guney, E; Meydan, N; Sargin, G; Tanriverdi, O; Taskin, F; Unubol, M1
Liao, G; Liu, H; Yan, Z1
Cambiaghi, N; Cavagnini, F; Corneo, G; Gambacorti-Passerini, C; Gnessi, L; Mariani, L; Pecori-Giraldi, F; Pogliani, E; Rossi, P; Tornaghi, L1
Chang, HM; Kang, HJ; Kang, YK; Kim, H; Kim, SE; Kim, TW; Lee, JS; Park, S; Ryu, MH; Sohn, HJ1

Reviews

2 review(s) available for imatinib mesylate and Gynecomastia

ArticleYear
Bilateral masculine mastoplasia associated with imatinib mesylate: a case report and literature review.
    Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2011, Volume: 31, Issue:1

    Topics: Adult; Antineoplastic Agents; Benzamides; Gynecomastia; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pyrimidines

2011
Imatinib-associated bilateral gynecomastia and unilateral testicular hydrocele in male patient with metastatic gastrointestinal stromal tumor: a literature review.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2012, Volume: 18, Issue:2

    Topics: Aged; Antineoplastic Agents; Benzamides; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gynecomastia; Humans; Imatinib Mesylate; Male; Piperazines; Pyrimidines; Testicular Hydrocele

2012

Other Studies

4 other study(ies) available for imatinib mesylate and Gynecomastia

ArticleYear
Low bone density and decreased inhibin-B/FSH ratio in a boy treated with imatinib during puberty.
    Lancet (London, England), 2008, Jul-12, Volume: 372, Issue:9633

    Topics: Antineoplastic Agents; Benzamides; Bone Density; Child; Follicle Stimulating Hormone; Gynecomastia; Humans; Imatinib Mesylate; Inhibins; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Puberty; Pyrimidines

2008
Gynecomastia during imatinib mesylate treatment for gastrointestinal stromal tumor: a rare adverse event.
    BMC gastroenterology, 2011, Nov-02, Volume: 11

    Topics: Adult; Aged; Benzamides; Estradiol; Estrogen Antagonists; Female; Gastrointestinal Stromal Tumors; Gynecomastia; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Tamoxifen; Testosterone

2011
Gynaecomastia in men with chronic myeloid leukaemia after imatinib.
    Lancet (London, England), 2003, Jun-07, Volume: 361, Issue:9373

    Topics: Antineoplastic Agents; Benzamides; Gynecomastia; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Progesterone; Pyrimidines; Testosterone

2003
Concurrent male gynecomastia and testicular hydrocele after imatinib mesylate treatment of a gastrointestinal stromal tumor.
    Journal of Korean medical science, 2005, Volume: 20, Issue:3

    Topics: Adult; Androgens; Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Gynecomastia; Humans; Imatinib Mesylate; Male; Piperazines; Pyrimidines; Testicular Hydrocele; Testis; Ultrasonography

2005